Lafayette, Colorado Clinical Trials

A listing of Lafayette, Colorado clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial)

This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important …

angina
ct scan
tumor cells
biomarker analysis
adjuvant chemotherapy
Kaiser Permanente-Rock Creek
 (0.5 away) Contact site
  • 433 views
  • 04 Jul, 2022
  • +937 other locations
An Internet-based Program to Help Cancer Survivors Manage Pain (IMPACTS)

To determine whether an Internet-based pain coping skills program plus enhanced usual care, compared to enhanced usual care alone, yields significant improvements in the co-primary outcomes of pain severity (as measured by the Brief Pain Inventory (BPI)) and pain interference (also measured by the BPI) from baseline to the post-intervention …

targeted therapy
cancer diagnosis
hormone therapy
treatment regimen
primary cancer
Kaiser Permanente-Rock Creek
 (0.5 away) Contact site
  • 0 views
  • 28 Jun, 2022
  • +58 other locations
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

This phase II/III trial studies the best dose of duloxetine and how well it works in preventing pain, tingling, and numbness (peripheral neuropathy) caused by treatment with oxaliplatin in patients with stage II-III colorectal cancer. Duloxetine increases the amount of certain chemicals in the brain that help relieve depression and …

Kaiser Permanente-Rock Creek
 (0.5 away) Contact site
  • 420 views
  • 22 Jul, 2022
  • +668 other locations
Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Study

This phase III trial studies how well pembrolizumab works compared to standard of care observation in treating patients with stage I-III Merkel cell cancer that has been completely removed by surgery (resected). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may …

Boulder Community Foothills Hospital
 (6.2 away) Contact site
  • 22 views
  • 22 Jul, 2022
  • +402 other locations
Trial for Treating Painful Degenerative Disc Disease

To evaluate and compare two platelet-based treatments of the functional spinal unit spaced 4 weeks apart to sham procedures for the treatment of degenerative disc disease.

Centeno-Schultz Clinic
 (7.6 away) Contact site
  • 0 views
  • 22 Jul, 2022
  • +1 other locations
Brentuximab Vedotin and Nivolumab With or Without Ipilimumab in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma

This phase I/II trial studies the side effects and best dose of ipilimumab and nivolumab when given together with brentuximab vedotin, and how well they work in treating patients with Hodgkin lymphoma that has returned after a period of improvement (recurrent) or has not responded to previous treatment (refractory). Immunotherapy …

Boulder Community Foothills Hospital
 (6.2 away) Contact site
  • 158 views
  • 24 Jul, 2022
  • +258 other locations
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas

This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma that is growing, spreading, or getting worse (progressive). Vismodegib, FAK inhibitor GSK2256098, capivasertib, and abemaciclib may stop the growth of tumor cells by blocking some of the enzymes …

gsk2256098
tumor cells
vismodegib
Rocky Mountain Cancer Centers-Thornton
 (9.8 away) Contact site
  • 4 views
  • 25 Jul, 2022
  • +510 other locations
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations

This phase II trial studies how well gemcitabine hydrochloride and cisplatin work in treating participants with invasive bladder urothelial cancer. Drugs used in chemotherapy, such as gemcitabine hydrochloride and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from …

Rocky Mountain Cancer Centers-Thornton
 (9.8 away) Contact site
  • 44 views
  • 25 Jul, 2022
  • +303 other locations
Testing the Addition of the Pill Chemotherapy, Cabozantinib, to the Standard Immune Therapy Nivolumab Compared to Standard Chemotherapy for Non-small Cell Lung Cancer

This phase II trial compares cabozantinib alone and the combination of cabozantinib and nivolumab to standard chemotherapy in the treatment of patients with non-squamous non-small cell lung cancer (NSCLC). Cabozantinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal …

bevacizumab
brain metastases
monoclonal antibodies
durvalumab
chronic hepatitis b
Boulder Community Foothills Hospital
 (6.2 away) Contact site
  • 25 views
  • 08 Aug, 2022
  • +438 other locations
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer

This trial studies how well atezolizumab added to the usual radiation therapy works in treating patients with stage I-IIA non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow …

ct scan
stereotactic body radiation therapy
atezolizumab
neutrophil count
kidney function test
Kaiser Permanente-Rock Creek
 (0.5 away) Contact site
  • 0 views
  • 09 Aug, 2022
  • +156 other locations